NCT01954992 2024-12-31
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Eleison Pharmaceuticals LLC.
Phase 3 Recruiting
Clinical Trials
4 trialsNCT00005053 2012-09-24
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00099294 2009-04-30
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
Threshold Pharmaceuticals
Phase 3 Completed
NCT00102752 2009-04-30
Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer
Threshold Pharmaceuticals
Phase 1/2 Completed